(Total Views: 136)
Posted On: 02/14/2023 4:05:46 PM
Post# of 224616
$TGTX News Article - TG Therapeutics Announces Data Presentations from the ULTIMATE I & II Phase 3 Trials of BRIUMVI(TM) (ublituximab) in Multiple Sclerosis to be Presented at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum https://marketwirenews.com/news-releases/tg-t...14461.html
(0)
(0)
My Twitter: WhyteStocks
